smallpox vaccine, heat-stable freeze-dried powder, first generation
Vaccineapproved
Approved
Jul 1, 1955
Clinical trial activity
9 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Nov 12, 2001 (NCT00026611)
Timeline
Indications
Approved for
Mechanism of action
- Variola virusImmunity, active
Variola virus immunity, active
Approval history
- approvedJul 1, 1955
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dryvax
- dryvax
- smallpox vaccine, heat-stable freeze-dried powder, first generation
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05762523 | Phase 1 | May 18, 2019 | Government of Russia |
| NCT00437021 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2007 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00032708 | Phase 2 | Apr 1, 2004 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00068198 | Phase 1 | Sep 9, 2003 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00053495 | Phase 2 | Jan 1, 2003 | Sanofi |
| NCT00053482 | Phase 2 | Jan 1, 2003 | Sanofi |
| NCT00053508 | Phase 2 | Sep 1, 2002 | Sanofi |
| NCT00042094 | Phase 1 | Mar 1, 2002 | DynPort Vaccine Company LLC |
| NCT00026611 | Phase 2 | Nov 12, 2001 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 4 | 4 | 2 | 2001 |
| Sanofi | For profit | 3 | 3 | 1 | 2002 |
| DynPort Vaccine Company LLC | For profit | 1 | 1 | 1 | 2002 |
| Government of Russia | Government | 1 | 1 | 1 | 2019 |
4 organizations
Page 1 / 1